Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al

Arthritis Rheum. 2003 Mar;48(3):864-6. doi: 10.1002/art.10781.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adult
  • Arthrography
  • Drug Therapy, Combination
  • Etanercept
  • Female
  • Histiocytosis, Non-Langerhans-Cell / diagnostic imaging
  • Histiocytosis, Non-Langerhans-Cell / drug therapy*
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Injections, Subcutaneous
  • Joints / pathology
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / therapeutic use*
  • Treatment Outcome

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Hydroxychloroquine
  • Etanercept